Centene Corporation Reports 2016 Third Quarter Results
-Diluted EPS of $0.84; Adjusted diluted EPS of $1.11, or $1.16 excluding a $0.05 charge from revised 2015 risk adjustment-

ST. LOUIS, Oct. 25, 2016 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced its financial results for the third quarter ended September 30, 2016.  The following discussions, with the exception of cash flow information, are in the context of continuing operations.

For the third quarter of 2016, we reported diluted earnings per share (EPS) of $0.84 and adjusted diluted EPS (Adjusted diluted EPS) of $1.11 when excluding Health Net acquisition related expenses and amortization of acquired intangible assets.  The third quarter of 2016 includes a $0.05 diluted EPS charge related to a revised reconciliation of the 2015 risk adjustment in Arizona.  During the third quarter, we received information from the Centers for Medicare and Medicaid Services (CMS) that some of the participants in the Arizona risk adjustment program were unable to pay the amounts owed to the Federal government associated with the 2015 risk adjustment reconciliation.  As a result, the uncollected risk adjustment was pro-rated to all insurers in the market.  Accordingly, we recorded a charge of $0.05 per diluted share recognizing our portion of the risk adjustment that will not be collected, which reduces the $0.19 diluted EPS benefit recorded in the second quarter.  A summary of diluted EPS is highlighted below:

GAAP diluted EPS

$

0.84

 

    Health Net acquisition related expenses

0.12

 

    Amortization of acquired intangible assets

0.15

 

      Adjusted diluted EPS

1.11

 

    2015 risk adjustment charge

0.05

 

      Total

$

1.16

 

During the third quarter of 2016, we continued to make progress on resolving the issues associated with the Health Net premium deficiency reserve.  Specifically, we took the following actions:

  • We reduced our estimate of the costs associated with the substance abuse claims from $50 million to $35 million for the period from March 24, 2016 through December 31, 2016. We continue to review substance abuse claim submissions and have lowered our estimate based on our experience through the third quarter. This adjustment had no impact on earnings.
  • As previously disclosed, we finalized our 2017 product design and premium rate filing with the California Department of Insurance associated with the individual preferred provider organization (PPO) and exclusive provider organization products. We believe the final product design and rate adjustments will attract a balanced mix of membership to ensure the product is competitive. Additionally, we continue to identify medical management and network initiatives to further improve performance.
  • We will exit the Arizona individual PPO business, effective January 1, 2017, which represents approximately $32 million of the $70 million 2016 Arizona individual premium deficiency reserve. Additionally, we will be the only carrier in Maricopa County and will continue our presence in Pima County for 2017. For 2017, based on our product designs and rate increases, we expect the Arizona Health Insurance Marketplace to operate within our normal marketplace margins.
  • We have taken various rate and product design actions in the small group business and continue to expect our Medicare and Arizona Medicaid business to be profitable in 2017.

As a result of the above actions, we believe we have resolved the issues associated with the premium deficiency reserve for 2017.

In summary, the 2016 third quarter results were as follows:

Total revenues (in millions)

$

10,846

   

Health benefits ratio

87.0

%

 

General & administrative expense ratio

9.2

%

 

General & administrative expense ratio, excluding Health Net acquisition related expenses

9.1

%

 

GAAP diluted EPS

$

0.84

   

Adjusted diluted EPS

$

1.11

   

Total cash flow provided by operations (in millions)

$

480

   

 

Michael F. Neidorff, Centene's Chairman and Chief Executive Officer, stated, "We remain focused on successfully integrating Health Net and positioning Centene to continue its track record of achieving profitable growth."

Third Quarter Highlights

  • September 30, 2016 managed care membership of 11.4 million, an increase of 6.6 million members, or 137% compared to the third quarter of 2015.
  • Total revenues for the third quarter of 2016 of $10.8 billion, representing 86% growth compared to the third quarter of 2015.
  • Health benefits ratio of 87.0% for the third quarter of 2016, compared to 89.0% in the third quarter of 2015.
  • General and administrative expense ratio of 9.2%, or 9.1% excluding Health Net acquisition related expenses for the third quarter of 2016, compared to 8.4% in the third quarter of 2015.
  • Operating cash flow of $480 million for the third quarter of 2016, or 3.3x net earnings.
  • Diluted EPS for the third quarter of 2016 of $0.84, or $1.11 of Adjusted diluted EPS. Both third quarter amounts included a charge of $0.05 associated with a revised reconciliation of the 2015 risk adjustment. In comparison, diluted EPS for the third quarter of 2015 was $0.75, or $0.87 Adjusted diluted EPS.

Other Events

  • In October 2016, our subsidiary, Home State Health, was selected to provide managed care services to MO HealthNet Managed Care beneficiaries. Under the new contract, Home State Health expects to serve MO HealthNet Managed Care beneficiaries in all 114 counties in Missouri. The contract is expected to commence May 1, 2017, pending regulatory approval.
  •  In September 2016, the Alabama legislature approved the funding needed to create its regional care organization (RCO) structure. Our subsidiary, AHA Administrative Services, has contracted with five nonprofit RCOs in Alabama to provide management services. Operations are expected to commence July 1, 2017.
  •  In August 2016, our Pennsylvania subsidiary, Pennsylvania Health & Wellness, was selected by the department of Human Services and Aging to serve enrollees in the Community HealthChoices program statewide. Expected contract commencement dates vary by zone, starting July 2017, and will be fully implemented by January 2019, pending regulatory approval.

Accreditations & Awards

  • In October 2016, our Kansas subsidiary, Sunflower Health Plan, received Accreditation with a Commendable status from the National Committee for Quality Assurance.
  • In August 2016, our subsidiaries, Envolve, Inc. and Envolve PeopleCare received honors at this year's National Health Information Awards. Envolve, Inc. received the merit award for the pamphlet Brush with Wisdom, while Envolve PeopleCare's Raising Well campaign won gold in the Health Information Program category.

Membership

The following table sets forth the Company's membership by state for its managed care organizations:

 

September 30,

 

2016

 

2015

Arizona

601,500

   

223,600

 

Arkansas

57,700

   

40,900

 

California

3,004,500

   

183,900

 

Florida

732,700

   

486,500

 

Georgia

498,000

   

406,700

 

Illinois

236,700

   

211,300

 

Indiana

289,600

   

276,700

 

Kansas

145,100

   

137,500

 

Louisiana

455,600

   

358,800

 

Massachusetts

45,300

   

63,700

 

Michigan

2,100

   

6,600

 

Minnesota

9,400

   

9,400

 

Mississippi

313,900

   

301,000

 

Missouri

104,700

   

88,400

 

New Hampshire

78,400

   

71,900

 

New Mexico

7,100

   

 

Ohio

319,500

   

308,100

 

Oregon

218,400

   

99,800

 

South Carolina

119,700

   

104,800

 

Tennessee

21,600

   

20,200

 

Texas

1,041,600

   

976,500

 

Vermont

1,700

   

1,500

 

Washington

240,500

   

208,600

 

Wisconsin

75,100

   

78,100

 

  Total at-risk membership

8,620,400

   

4,664,500

 

TRICARE eligibles

2,815,700

   

 

Non-risk membership

   

169,900

 

  Total

11,436,100

   

4,834,400

 

 

The following table sets forth our membership by line of business:

 

September 30,

 

2016

 

2015

Medicaid:

     

  TANF, CHIP & Foster Care

5,583,900

   

3,719,900

 

  ABD & LTC

754,900

   

473,700

 

  Behavioral Health

465,300

   

216,700

 

Commercial

1,365,600

   

155,600

 

Medicare & Duals

300,900

   

39,300

 

Correctional

149,800

   

59,300

 

  Total at-risk membership

8,620,400

   

4,664,500

 

TRICARE eligibles

2,815,700

   

 

Non-risk membership

   

169,900

 

  Total

11,436,100

   

4,834,400

 

 

At September 30, 2016, the Company served 1,048,500 members in Medicaid expansion programs in ten states, compared to 442,600 members in eight states at September 30, 2015.  At September 30, 2016, the Company served 369,300 dual-eligible members, compared to 200,900 at September 30, 2015.  At September 30, 2016, the Company served 582,600 members in Health Insurance Marketplaces, compared to 155,600 at September 30, 2015.

Statement of Operations: Three Months Ended September 30, 2016

  • For the third quarter of 2016, total revenues increased 86% to $10.8 billion from $5.8 billion in the comparable period in 2015 and decreased sequentially from $10.9 billion in the second quarter of 2016. The increase over prior year was primarily as a result of the acquisition of Health Net, as well as the impact from expansions and new programs in many of our states in 2015 and 2016 and growth in the Health Insurance Marketplace business in 2016. The decrease in revenue over the second quarter of 2016 is primarily a result of lower commercial membership driven by Health Insurance Marketplace attrition and lower California Medicaid membership driven by the state's annual eligibility redetermination process, partially offset by increased revenue due to the commencement of Medicaid expansion in Louisiana.
  • HBR of 87.0% for the third quarter of 2016 represents a decrease from 89.0% in the comparable period in 2015 and an increase from 86.6% in the second quarter of 2016. The year over year HBR decrease is primarily attributable to the acquisition of Health Net, which operates at a lower HBR due to a greater mix of commercial business. The sequential increase is due to normal seasonality.
  • G&A expense ratio of 9.2%, or 9.1% excluding Health Net acquisition related expenses, for the third quarter of 2016, compared to 8.4%, or 8.1% excluding Health Net acquisition related expenses, in the third quarter of 2015. The increase in the G&A expense ratio is primarily attributable to the addition of the Health Net business, which operates at a higher G&A ratio due to a greater mix of commercial and Medicare business.
  • Diluted EPS for the third quarter of 2016 of $0.84, or $1.11 of Adjusted diluted EPS, both including a $0.05 diluted EPS charge related to a revised reconciliation of the 2015 risk adjustment under the ACA in connection with our Health Insurance Marketplace business. In comparison, diluted EPS for the third quarter of 2015 was $0.75, or $0.87 Adjusted diluted EPS.

Balance Sheet and Cash Flow

At September 30, 2016, the Company had cash, investments and restricted deposits of $8.1 billion, including $268 million held by its unregulated entities.  Medical claims liabilities totaled $3.8 billion.  The Company's days in claims payable was 41.  Total debt was $4.6 billion, which includes $300 million of borrowings on the $1.0 billion revolving credit facility at quarter-end.  The debt to capitalization ratio was 44.1% at September 30, 2016, excluding the $65 million non-recourse mortgage note.

Cash flow provided by operations for the three months ended September 30, 2016, was $480 million. The cash provided by operating activities in 2016 primarily reflects net earnings and an increase in unearned revenue.

A reconciliation of the Company's change in days in claims payable from the immediately preceding quarter-end is presented below:

 

     

Days in claims payable, June 30, 2016

 

43

  Payment of annual provider risk share settlement

 

(1)

  Timing of claims payments

 

(1)

Days in claims payable, September 30, 2016

 

41

     

 

Outlook

The Company has adjusted its GAAP and Adjusted diluted EPS guidance ranges reflecting the charge associated with the 2015 Arizona risk adjustment reconciliation recorded in the third quarter.  The table below depicts the Company's updated annual guidance for 2016.

   

Full Year 2016

 
   

Low

 

High

 

Total revenues (in billions)

 

$

39.4

   

$

40.0

   

GAAP diluted EPS

 

$

2.73

   

$

2.83

   

Adjusted diluted EPS (1)

 

$

4.28

   

$

4.38

   

HBR

 

87.0

%

 

87.5

%

 

G&A expense ratio

 

9.4

%

 

9.9

%

 

G&A expense ratio, excluding acquisition related costs (2)

 

9.0

%

 

9.5

%

 

Effective tax rate

 

54.5

%

 

56.5

%

 

Diluted shares outstanding (in millions)

 

162.5

   

163.5

   
           
 

(1)Adjusted diluted EPS excludes Health Net acquisition related expenses of $1.00 to $1.05 per diluted share and amortization of acquired intangible assets of $0.50 to $0.55 per diluted share.

 

(2)The G&A expense ratio excludes Health Net acquisition related expenses of approximately $225 million to $240 million.

 

The guidance above implies a fourth quarter GAAP diluted EPS guidance range of $0.83 to $0.93 and Adjusted diluted EPS guidance range of $1.05 to $1.15.

Conference Call

As previously announced, the Company will host a conference call Tuesday, October 25, 2016, at 8:30 AM (Eastern Time) to review the financial results for the third quarter ended September 30, 2016, and to discuss its business outlook.  Michael Neidorff and Jeffrey Schwaneke will host the conference call. 

Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 2467001 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com , under the Investors section.

A webcast replay will be available for on-demand listening shortly after the completion of the call for the next twelve months or until 11:59 PM (Eastern Time) on Tuesday, October 24, 2017, at the aforementioned URL. In addition, a digital audio playback will be available until 9:00 AM Eastern Time on Tuesday, November 1, 2016, by dialing 1-877-344-7529 in the U.S. and Canada, or +1-412-317-0088 from abroad, and entering access code 10093224.

Non-GAAP Financial Presentation

The Company is providing certain non-GAAP financial measures in this release as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company's operations and measure the Company's performance more consistently across periods. The Company uses the presented non-GAAP financial measures internally to allow management to focus on period-to-period changes in the Company's core business operations. Therefore, the Company believes that this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.

Specifically, the Company believes the presentation of non-GAAP financial information that excludes Health Net acquisition related expenses and amortization of acquired intangible assets allows investors to develop a more meaningful understanding of the Company's performance over time.  The tables below provide a reconciliation of non-GAAP items ($ in millions, except per share data): 

 

 

 

Three Months Ended

September 30,

 

Nine Months Ended

September 30,

   
 

2016

 

2015

 

2016

 

2015

   
                   

GAAP general and administrative expenses

$

940

   

$

458

   

$

2,611

   

$

1,291

     

Health Net acquisition related expenses

10

   

18

   

224

   

20

     

General and administrative expenses, excluding Health Net acquisition related expenses

$

930

   

$

440

   

$

2,387

   

$

1,271

     
                   

GAAP net earnings from continuing operations

$

146

   

$

92

   

$

300

   

$

244

     

Health Net acquisition related expenses

10

   

18

   

224

   

20

     

Amortization of acquired intangible assets

43

   

6

   

95

   

18

     

Income tax effects of adjustments (1)

(5)

   

(9)

   

(106)

   

(14)

     

Adjusted net earnings from continuing operations

$

194

   

$

107

   

$

513

   

$

268

     
                   
 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

Annual
Guidance
December 31,
2016

 

2016

 

2015

 

2016

 

2015

 

GAAP diluted EPS

$

0.84

   

$

0.75

   

$

1.89

   

$

1.99

   

$2.73 - $2.83

Health Net acquisition related expenses (2)

0.12

   

0.09

   

0.98

   

0.10

   

$1.00 - $1.05

Amortization of acquired intangible assets (3)

0.15

   

0.03

   

0.36

   

0.09

   

$0.50 - $0.55

  Adjusted diluted EPS

$

1.11

   

$

0.87

   

$

3.23

   

$

2.18

   

$4.28 - $4.38

   

(1)

The income tax effects of adjustments are based on the effective income tax rates applicable to adjusted (non-GAAP) results. The amounts are based on the annual estimated effective income tax rate that would increase or decrease based on the exclusion of these expenses.

   

(2)

The Health Net acquisition related expenses per diluted share presented above are net of the income tax benefit (expense) of $(0.06) and $0.05 for the three months ended September 30, 2016 and 2015, respectively, and $0.44 and $0.06 for the nine months ended September 30, 2016 and 2015, respectively; and estimated $0.37 to $0.41 for the year ended December 31, 2016.

   

(3)

The amortization of acquired intangible assets per diluted share presented above are net of the income tax benefit of $0.09 and $0.02 for the three months ended September 30, 2016 and 2015, respectively, and $0.23 and $0.05 for the nine months ended September 30, 2016 and 2015, respectively; and estimated $0.31 to $0.35 for the year ended December 31, 2016.

 

About Centene Corporation

Centene Corporation is a diversified, multi-national healthcare enterprise that provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. Many receive benefits provided under Medicaid, including the State Children's Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care and Long Term Care (LTC), in addition to other state-sponsored programs, Medicare (including the Medicare prescription drug benefit commonly known as "Part D"), dual eligible programs and programs with the U.S. Department of Defense and U.S. Department of Veterans Affairs. Centene also provides healthcare services to groups and individuals delivered through commercial health plans. Centene operates local health plans and offers a range of health insurance solutions. It also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health management, care management software, correctional healthcare services, dental benefits management, in-home health services, life and health management, managed vision, pharmacy benefits management, specialty pharmacy and telehealth services.

Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, http://www.centene.com/investors.

Forward-Looking Statements

The company and its representatives may from time to time make written and oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act ("PSLRA") of 1995, including statements in this and other press releases, in presentations, filings with the Securities and Exchange Commission ("SEC"), reports to stockholders and in meetings with investors and analysts. In particular, the information provided in this press release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of Centene and certain plans and objectives of Centene with respect thereto, including but not limited to the expected benefits of the acquisition of Health Net, Inc.. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Without limiting the foregoing, forward-looking statements often use words such as "anticipate", "seek", "target", "expect", "estimate", "intend", "plan", "goal", "believe", "hope", "aim", "continue", "will", "may", "can", "would", "could" or "should" or other words of similar meaning or the negative thereof. We intend such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in PSLRA.  A number of factors, variables or events could cause actual plans and results to differ materially from those expressed or implied in forward-looking statements. Such factors include, but are not limited to, Centene's ability to accurately predict and effectively manage health benefits and other operating expenses and reserves; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies and advances in medicine; increased health care costs; inflation; foreign currency fluctuations; tax matters; availability of debt and equity financing, on terms that are favorable to Centene; disasters or major epidemics; changes in economic, political or market conditions; the outcome of legal or regulatory proceedings; changes in federal or state laws or regulations, including the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act and any regulations enacted thereunder; changes in expected contract start dates; provider, state, federal and other contract changes and timing of regulatory approval of contracts; the expiration, suspension or termination of Centene's contracts with federal or state governments (including but not limited to Medicaid, Medicare, and TRICARE); challenges to Centene's contract awards; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting Centene's government businesses; Centene's ability to adequately price products on federally facilitated and state based Health Insurance Marketplaces; cyber-attacks or other privacy or data security incidents; the possibility that the expected synergies and value creation from acquired businesses, including, without limitation, the Health Net acquisition, will not be realized, or will not be realized within the expected time period, including, but not limited to, as a result of conditions, terms, obligations or restrictions imposed by regulators in connection with their approval of, or consent to, the acquisition; the exertion of management's time and Centene's resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with certain regulatory approvals; disruption from the acquisition making it more difficult to maintain business and operational relationships; the risk that unexpected costs will be incurred in connection with, among other things, the acquisition and/or the integration; changes in expected closing dates, estimated purchase price and accretion for acquisitions; the risk that acquired businesses will not be integrated successfully; Centene's ability to maintain or achieve improvement in CMS Star ratings and other quality scores that impact revenue; and risks and uncertainties discussed in the reports that Centene has filed with the SEC. These forward-looking statements reflect Centene's current views with respect to future events and are based on numerous assumptions and assessments made by Centene in light of its experience and perception of historical trends, current conditions, business strategies, operating environments, future developments and other factors it believes appropriate. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future.  The factors described in the context of such forward-looking statements in this press release could cause Centene's plans with respect to the Health Net acquisition, actual results, performance or achievements, industry results and developments to differ materially from those expressed in or implied by such forward-looking statements. Although it is currently believed that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct and persons reading this press release are therefore cautioned not to place undue reliance on these forward-looking statements which speak only as of the date of this press release. Centene does not assume any obligation to update the information contained in this press release (whether as a result of new information, future events or otherwise), except as required by applicable law.  This list of important factors is not intended to be exhaustive. We discuss certain of these matters more fully, as well as certain other risk factors that may affect Centene's business operations, financial condition and results of operations, in Centene's filings with the SEC, including the annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

[Tables Follow]

CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In millions, except share data)

 
 
 

September 30, 2016

 

December 31, 2015

 

(Unaudited)

   

ASSETS

     

Current assets:

     

Cash and cash equivalents

$

2,982

   

$

1,760

 

Premium and related receivables

3,445

   

1,279

 

Short term investments

406

   

176

 

Other current assets

922

   

390

 

Total current assets

7,755

   

3,605

 

Long term investments

4,568

   

1,927

 

Restricted deposits

137

   

115

 

Property, software and equipment, net

725

   

518

 

Goodwill

4,730

   

842

 

Intangible assets, net

1,566

   

155

 

Other long term assets

153

   

177

 

Total assets

$

19,634

   

$

7,339

 
       

LIABILITIES AND STOCKHOLDERS' EQUITY

     

Current liabilities:

     

Medical claims liability

$

3,767

   

$

2,298

 

Accounts payable and accrued expenses

3,187

   

976

 

Return of premium payable

651

   

207

 

Unearned revenue

573

   

143

 

Current portion of long term debt

845

   

5

 

Total current liabilities

9,023

   

3,629

 

Long term debt

3,744

   

1,216

 

Other long term liabilities

995

   

170

 

Total liabilities

13,762

   

5,015

 

Commitments and contingencies

     

Redeemable noncontrolling interests

148

   

156

 

Stockholders' equity:

     

Preferred stock, $0.001 par value; authorized 10,000,000 shares; no shares issued or outstanding at September 30, 2016 and December 31, 2015

   

 

Common stock, $0.001 par value; authorized 400,000,000 shares; 176,467,825 issued and 170,860,752 outstanding at September 30, 2016, and 126,855,477 issued and 120,342,981 outstanding at December 31, 2015

   

 

Additional paid-in capital

4,154

   

956

 

Accumulated other comprehensive earnings (loss)

46

   

(10)

 

Retained earnings

1,655

   

1,358

 

Treasury stock, at cost (5,607,073 and 6,512,496 shares, respectively)

(145)

   

(147)

 

Total Centene stockholders' equity

5,710

   

2,157

 

Noncontrolling interest

14

   

11

 

Total stockholders' equity

5,724

   

2,168

 

Total liabilities and stockholders' equity

$

19,634

   

$

7,339

 

 

 

 

CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(In millions, except share data)

(Unaudited)

 
 
 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

2016

 

2015

 

2016

 

2015

Revenues:

             

  Premium

$

9,625

   

$

4,983

   

$

25,299

   

$

13,974

 

  Service

590

   

480

   

1,603

   

1,434

 

  Premium and service revenues

10,215

   

5,463

   

26,902

   

15,408

 

  Premium tax and health insurer fee

631

   

358

   

1,794

   

1,050

 

    Total revenues

10,846

   

5,821

   

28,696

   

16,458

 

Expenses:

             

  Medical costs

8,376

   

4,433

   

22,072

   

12,475

 

  Cost of services

504

   

413

   

1,386

   

1,234

 

  General and administrative expenses

940

   

458

   

2,611

   

1,291

 

  Amortization of acquired intangible assets

43

   

6

   

95

   

18

 

  Premium tax expense

512

   

274

   

1,460

   

794

 

  Health insurer fee expense

129

   

54

   

333

   

161

 

  Total operating expenses

10,504

   

5,638

   

27,957

   

15,973

 

  Earnings from operations

342

   

183

   

739

   

485

 

Other income (expense):

             

  Investment and other income

33

   

8

   

80

   

27

 

  Interest expense

(57)

   

(11)

   

(142)

   

(32)

 

  Earnings from continuing operations, before income tax expense

318

   

180

   

677

   

480

 

  Income tax expense

171

   

87

   

376

   

234

 

  Earnings from continuing operations, net of income tax expense

147

   

93

   

301

   

246

 

Discontinued operations, net of income tax benefit

(1)

   

1

   

(3)

   

 

  Net earnings

146

   

94

   

298

   

246

 

(Earnings) attributable to noncontrolling interests

(1)

   

(1)

   

(1)

   

(2)

 

  Net earnings attributable to Centene Corporation

$

145

   

$

93

   

$

297

   

$

244

 
               

Amounts attributable to Centene Corporation common shareholders:

  Earnings from continuing operations, net of income tax expense

$

146

   

$

92

   

$

300

   

$

244

 

  Discontinued operations, net of income tax benefit

(1)

   

1

   

(3)

   

 

    Net earnings

$

145

   

$

93

   

$

297

   

$

244

 
               

Net earnings (loss) per common share attributable to Centene Corporation:

  Basic:

             

    Continuing operations

$

0.85

   

$

0.77

   

$

1.93

   

$

2.05

 

    Discontinued operations

   

0.01

   

(0.02)

   

 

    Basic earnings per common share

$

0.85

   

$

0.78

   

$

1.91

   

$

2.05

 
               

  Diluted:

             

    Continuing operations

$

0.84

   

$

0.75

   

$

1.89

   

$

1.99

 

    Discontinued operations

(0.01)

   

0.01

   

(0.02)

   

 

    Diluted earnings per common share

$

0.83

   

$

0.76

   

$

1.87

   

$

1.99

 
               

Weighted average number of common shares outstanding:

       

  Basic

170,774,587

 

119,121,524

 

155,680,769

 

118,970,853

  Diluted

174,312,416

 

123,131,810

 

158,960,068

 

122,904,476

 

 

CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In millions)

(Unaudited)

 
 
 

Nine Months Ended September 30,

 

2016

 

2015

Cash flows from operating activities:

     

Net earnings

$

298

   

$

246

 

Adjustments to reconcile net earnings to net cash provided by operating activities

Depreciation and amortization

189

   

82

 

Stock compensation expense

112

   

48

 

Deferred income taxes

(17)

   

(14)

 

Gain on contingent consideration

(2)

   

(37)

 

Goodwill and intangible adjustment

   

28

 

Changes in assets and liabilities

     

Premium and related receivables

(906)

   

(360)

 

Other current assets

(81)

   

(103)

 

Medical claims liabilities

15

   

394

 

Unearned revenue

301

   

(104)

 

Accounts payable and accrued expenses

99

   

209

 

Other long term liabilities

156

   

101

 

Other operating activities, net

91

   

(33)

 

Net cash provided by operating activities

255

   

457

 

Cash flows from investing activities:

     

Capital expenditures

(211)

   

(101)

 

Purchases of investments

(1,528)

   

(1,077)

 

Sales and maturities of investments

955

   

418

 

Investments in acquisitions, net of cash acquired

(848)

   

(16)

 

Other investing activities, net

   

7

 

Net cash used in investing activities

(1,632)

   

(769)

 

Cash flows from financing activities:

     

Proceeds from borrowings

6,956

   

1,305

 

Payment of long term debt

(4,257)

   

(910)

 

Common stock repurchases

(29)

   

(9)

 

Purchase of noncontrolling interest

(14)

   

 

Debt issue costs

(59)

   

(4)

 

Other financing activities, net

1

   

(15)

 

Net cash provided by financing activities

2,598

   

367

 

Effect of exchange rate changes on cash and cash equivalents

1

   

 

Net increase in cash and cash equivalents

1,222

   

55

 

Cash and cash equivalents, beginning of period

1,760

   

1,610

 

Cash and cash equivalents, end of period

$

2,982

   

$

1,665

 

Supplemental disclosures of cash flow information:

     

Interest paid

$

113

   

$

28

 

Income taxes paid

$

394

   

$

229

 

Equity issued in connection with acquisitions

$

3,105

   

$

12

 

 

CENTENE CORPORATION

SUPPLEMENTAL FINANCIAL DATA FROM CONTINUING OPERATIONS

 
 
   

Q3

 

Q2

 

Q1

 

Q4

 

Q3

 
   

2016

 

2016

 

2016

 

2015

 

2015

 

MANAGED CARE MEMBERSHIP BY STATE

     

Arizona

 

601,500

   

597,700

   

607,000

   

440,900

   

223,600

   

Arkansas

 

57,700

   

52,800

   

50,700

   

41,900

   

40,900

   

California

 

3,004,500

   

3,097,600

   

3,125,400

   

186,000

   

183,900

   

Florida

 

732,700

   

726,200

   

660,800

   

510,400

   

486,500

   

Georgia

 

498,000

   

493,300

   

495,500

   

408,600

   

406,700

   

Illinois

 

236,700

   

234,700

   

239,100

   

207,500

   

211,300

   

Indiana

 

289,600

   

291,000

   

290,300

   

282,100

   

276,700

   

Kansas

 

145,100

   

144,800

   

141,100

   

141,000

   

137,500

   

Louisiana

 

455,600

   

375,300

   

381,200

   

381,900

   

358,800

   

Massachusetts

 

45,300

   

47,100

   

52,400

   

61,500

   

63,700

   

Michigan

 

2,100

   

2,200

   

2,600

   

4,800

   

6,600

   

Minnesota

 

9,400

   

9,500

   

9,500

   

9,600

   

9,400

   

Mississippi

 

313,900

   

323,800

   

328,300

   

302,200

   

301,000

   

Missouri

 

104,700

   

102,900

   

100,000

   

95,100

   

88,400

   

New Hampshire

 

78,400

   

79,700

   

81,500

   

71,400

   

71,900

   

New Mexico

 

7,100

   

7,100

   

   

   

   

Ohio

 

319,500

   

319,000

   

314,000

   

302,700

   

308,100

   

Oregon

 

218,400

   

221,500

   

209,000

   

98,700

   

99,800

   

South Carolina

 

119,700

   

113,700

   

107,700

   

104,000

   

104,800

   

Tennessee

 

21,600

   

20,800

   

20,100

   

20,000

   

20,200

   

Texas

 

1,041,600

   

1,037,000

   

1,036,700

   

983,100

   

976,500

   

Vermont

 

1,700

   

1,600

   

1,500

   

1,700

   

1,500

   

Washington

 

240,500

   

239,700

   

226,500

   

209,400

   

208,600

   

Wisconsin

 

75,100

   

76,100

   

78,400

   

77,100

   

78,100

   

Total at-risk membership

 

8,620,400

   

8,615,100

   

8,559,300

   

4,941,600

   

4,664,500

   

TRICARE eligibles

 

2,815,700

   

2,815,700

   

2,819,700

   

   

   

Non-risk membership

 

   

   

161,400

   

166,300

   

169,900

   

Total

 

11,436,100

   

11,430,800

   

11,540,400

   

5,107,900

   

4,834,400

   
                       
 

Medicaid:

                     

  TANF, CHIP & Foster Care

 

5,583,900

   

5,541,200

   

5,464,200

   

3,763,400

   

3,719,900

   

  ABD & LTC

 

754,900

   

757,500

   

757,600

   

478,600

   

473,700

   

  Behavioral Health

 

465,300

   

455,800

   

456,500

   

456,800

   

216,700

   

Commercial

 

1,365,600

   

1,423,400

   

1,518,900

   

146,100

   

155,600

   

Medicare & Duals

 

300,900

   

300,700

   

303,100

   

37,400

   

39,300

   

Correctional

 

149,800

   

136,500

   

59,000

   

59,300

   

59,300

   

  Total at-risk membership

 

8,620,400

   

8,615,100

   

8,559,300

   

4,941,600

   

4,664,500

   

TRICARE eligibles

 

2,815,700

   

2,815,700

   

2,819,700

   

   

   

Non-risk membership

 

   

   

161,400

   

166,300

   

169,900

   

  Total

 

11,436,100

   

11,430,800

   

11,540,400

   

5,107,900

   

4,834,400

   
                       

NUMBER OF EMPLOYEES

 

29,400

   

28,900

   

28,000

   

18,200

   

17,100

   

 

 

 

Q3

 

Q2

 

Q1

 

Q4

 

Q3

 
 

2016

 

2016

 

2016

 

2015

 

2015

 
                     

DAYS IN CLAIMS PAYABLE  (a)

41

   

43

   

66

   

44

   

45

   

(a) Days in claims payable is a calculation of medical claims liabilities at the end of the period divided by average claims expense per calendar day for such period.  On a pro-forma basis, DCP for Q1 2016 was 42, reflecting adjusted medical costs to include a full quarter of Health Net operations.

                     

CASH, INVESTMENTS AND RESTRICTED DEPOSITS (in millions)

  Regulated

$

7,825

   

$

7,324

   

$

7,682

   

$

3,900

   

$

3,834

   

  Unregulated

268

   

196

   

139

   

78

   

91

   

    Total

$

8,093

   

$

7,520

   

$

7,821

   

$

3,978

   

$

3,925

   
                     

DEBT TO CAPITALIZATION

44.5

%

 

44.8

%

 

44.6

%

 

36.0

%

 

38.4

%

 

DEBT TO CAPITALIZATION EXCLUDING NON-RECOURSE DEBT (b)

44.1

%

 

44.4

%

 

44.3

%

 

34.7

%

 

37.1

%

 

(b) The non-recourse debt represents the Company's mortgage note payable ($65 million at September 30, 2016).

Debt to capitalization is calculated as follows: total debt divided by (total debt + total equity).

 

OPERATING RATIOS

 
 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

2016

 

2015

 

2016

 

2015

Health benefits ratio

87.0

%

 

89.0

%

 

87.2

%

 

89.3

%

General & administrative expense ratio

9.2

%

 

8.4

%

 

9.7

%

 

8.4

%

General & administrative expense ratio, excluding Health Net acquisition related expenses

9.1

%

 

8.1

%

 

8.9

%

 

8.2

%

 

MEDICAL CLAIMS LIABILITY

 

The changes in medical claims liability are summarized as follows (in millions):

 

Balance, September 30, 2015

 

$

2,144

 

  Acquisitions

 

1,453

 

  Incurred related to:

   

   Current period

 

27,094

 

   Prior period

 

(255)

 

     Total incurred

 

26,839

 

   Paid related to:

   

     Current period

 

24,807

 

     Prior period

 

1,862

 

      Total paid

 

26,669

 

Balance, September 30, 2016

 

$

3,767

 

 

Centene's claims reserving process utilizes a consistent actuarial methodology to estimate Centene's ultimate liability.  Any reduction in the "Incurred related to: Prior period" amount may be offset as Centene actuarially determines "Incurred related to: Current period."  As such, only in the absence of a consistent reserving methodology would favorable development of prior period claims liability estimates reduce medical costs.  Centene believes it has consistently applied its claims reserving methodology in each of the periods presented.  Additionally, as a result of minimum HBR and other return of premium programs, approximately $22 million of the "Incurred related to: Prior period" was recorded as a reduction to premium revenues.

The amount of the "Incurred related to: Prior period" above represents favorable development and includes the effects of reserving under moderately adverse conditions, new markets where we use a conservative approach in setting reserves during the initial periods of operations, receipts from other third party payors related to coordination of benefits and lower medical utilization and cost trends for dates of service September 30, 2015, and prior.

Logo - http://photos.prnewswire.com/prnh/20141030/155662LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/centene-corporation-reports-2016-third-quarter-results-300350242.html

SOURCE Centene Corporation